Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1c.
暂无分享,去创建一个
[1] N. Clark,et al. Standards of Medical Care in Diabetes: Response to Power , 2006 .
[2] B. Zinman,et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. , 2005, The New England journal of medicine.
[3] S. Kaplan,et al. Self‐monitoring of blood glucose in non‐insulin‐treated diabetic patients: a longitudinal evaluation of its impact on metabolic control , 2005, Diabetic medicine : a journal of the British Diabetic Association.
[4] S. Kaplan,et al. Self‐monitoring of blood glucose in non‐insulin‐treated diabetic patients: a longitudinal evaluation of its impact on metabolic control , 2005 .
[5] N. Evans,et al. Fluorescence-based glucose sensors. , 2005, Biosensors & bioelectronics.
[6] L. Bouter,et al. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. , 2005, Diabetes care.
[7] M. Davidson,et al. Counterpoint: Self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin: a waste of money. , 2005, Diabetes care.
[8] R. Little,et al. Effects of hemoglobin C and S traits on glycohemoglobin measurements by eleven methods. , 2005, Clinical chemistry.
[9] M. Davidson,et al. The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. , 2005, The American journal of medicine.
[10] D. Sacks. Global harmonization of hemoglobin A1c. , 2005, Clinical chemistry.
[11] Bruce A Buckingham,et al. Accuracy of the modified Continuous Glucose Monitoring System (CGMS) sensor in an outpatient setting: results from a diabetes research in children network (DirecNet) study. , 2005, Diabetes technology & therapeutics.
[12] Kathryn Tan,et al. Self-monitoring of blood glucose as part of a multi-component therapy among non-insulin requiring type 2 diabetes patients: a meta-analysis (1966–2004)* , 2005, Current medical research and opinion.
[13] Claresa Levetan,et al. Use of the Continuous Glucose Monitoring System to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial. , 2004, Mayo Clinic proceedings.
[14] M. Parchman,et al. Association between self-monitoring of blood glucose and glycemic control in patients with type 2 diabetes mellitus. , 2004, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[15] C. Edwards. International Textbook of Diabetes Mellitus , 2004 .
[16] A. Wierzbicki,et al. Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes. , 2004, Diabetes care.
[17] Neil R. Powe,et al. Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus , 2004, Annals of Internal Medicine.
[18] Janet B McGill,et al. Circulating 1,5-anhydroglucitol levels in adult patients with diabetes reflect longitudinal changes of glycemia: a U.S. trial of the GlycoMark assay. , 2004, Diabetes care.
[19] S. Majumdar,et al. Lack of insurance coverage for testing supplies is associated with poorer glycemic control in patients with type 2 diabetes , 2004, Canadian Medical Association Journal.
[20] A. Carter,et al. A prospective, randomized, multicentered controlled trial to compare the annual glycemic and quality outcomes of patients with diabetes mellitus monitored with weekly fructosamine testing versus usual care. , 2004, Diabetes technology & therapeutics.
[21] James D Dziura,et al. Experience with the continuous glucose monitoring system in a medical intensive care unit. , 2004, Diabetes technology & therapeutics.
[22] P. Damm,et al. HbA1c levels are significantly lower in early and late pregnancy. , 2004, Diabetes care.
[23] H. Lapinski,et al. Self-monitoring of blood glucose in diabetic patients: from the least common denominator to the greatest common multiple. , 2004, Diabetes & metabolism.
[24] M. Barton,et al. Effects of health maintenance organization coverage of self-monitoring devices on diabetes self-care and glycemic control. , 2004, Archives of internal medicine.
[25] C. Chia,et al. Glucose sensors: toward closed loop insulin delivery. , 2004, Endocrinology and metabolism clinics of North America.
[26] P Drouin,et al. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. , 2003, Diabetes & metabolism.
[27] C. Saudek,et al. Is HbA(1c) affected by glycemic instability? , 2003, Diabetes care.
[28] D. Hadden,et al. Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. , 2003, American journal of obstetrics and gynecology.
[29] Arleen F. Brown,et al. Out-of-pocket costs and diabetes preventive services: the Translating Research Into Action for Diabetes (TRIAD) study. , 2003, Diabetes care.
[30] Hee-Seung Kim,et al. Establishment of blood glucose monitoring system using the internet. , 2003, Diabetes care.
[31] Dawn M. Bina,et al. Clinical impact of prandial state, exercise, and site preparation on the equivalence of alternative-site blood glucose testing. , 2003, Diabetes care.
[32] L. Phillips,et al. Rapid A1c availability improves clinical decision-making in an urban primary care clinic. , 2003, Diabetes care.
[33] Claude Colette,et al. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). , 2003, Diabetes care.
[34] R. Hanås. Psychological impact of changing the scale of reported HbA(1c) results affects metabolic control. , 2002, Diabetes care.
[35] G. Mertes,et al. Meal-related structured self-monitoring of blood glucose: effect on diabetes control in non-insulin-treated type 2 diabetic patients. , 2002, Diabetes care.
[36] Stefano Zucchini,et al. The glucose area under the profiles obtained with continuous glucose monitoring system relationships with HbA(lc) in pediatric type 1 diabetic patients. , 2002, Diabetes care.
[37] Ralph B D'Agostino,et al. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. , 2002, Diabetes care.
[38] R. McCarter,et al. High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control. , 2002, Journal of diabetes and its complications.
[39] David M Nathan,et al. Tests of Glycemia for the Diagnosis of Type 2 Diabetes Mellitus , 2002, Annals of Internal Medicine.
[40] R. Little,et al. Biological variation of glycohemoglobin. , 2002, Clinical chemistry.
[41] John M Ellison,et al. Rapid changes in postprandial blood glucose produce concentration differences at finger, forearm, and thigh sampling sites. , 2002, Diabetes care.
[42] Matthew D. Davis,et al. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. , 2002, JAMA.
[43] D. Goldstein,et al. Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. , 2002, Diabetes care.
[44] R. Paroni,et al. Approved IFCC Reference Method for the Measurement of HbA1c in Human Blood , 2002, Clinical chemistry and laboratory medicine.
[45] R. Kronmal,et al. Fasting and 2-hour postchallenge serum glucose measures and risk of incident cardiovascular events in the elderly: the Cardiovascular Health Study. , 2002, Archives of internal medicine.
[46] S H Kaplan,et al. The impact of blood glucose self-monitoring on metabolic control and quality of life in type 2 diabetic patients: an urgent need for better educational strategies. , 2001, Diabetes care.
[47] Jennifer Y. Liu,et al. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. , 2001, The American journal of medicine.
[48] M. Harris,et al. Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes. , 2001, Diabetes care.
[49] J. Baker,et al. Error detection and measurement in glucose monitors. , 2001, Clinica chimica acta; international journal of clinical chemistry.
[50] L. Bry,et al. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. , 2001, Clinical chemistry.
[51] Dawn M. Bina,et al. Identifying Variables Associated With Inaccurate Self-Monitoring of Blood Glucose: Proposed Guidelines to Improve Accuracy , 2000, The Diabetes educator.
[52] M. Gulliford,et al. Self‐monitoring in Type 2 diabetes mellitus: a meta‐analysis , 2000, Diabetic medicine : a journal of the British Diabetic Association.
[53] R. Holman,et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study , 2000, BMJ : British Medical Journal.
[54] K. Flegal,et al. Use of GHb (HbA1c) in screening for undiagnosed diabetes in the U.S. population. , 2000, Diabetes care.
[55] J. Chanard,et al. Influence of in vivo Hemoglobin Carbamylation on HbA1c Measurements by Various Methods , 2000, Clinical chemistry and laboratory medicine.
[56] D. Nathan,et al. Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients. , 1999, Diabetes care.
[57] John J Mastrototaro,et al. Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoring. , 1999, American journal of physiology. Endocrinology and metabolism.
[58] Ö. Tarım,et al. Effects of iron deficiency anemia on hemoglobin A1c in type 1 diabetes mellitus , 1999, Pediatrics international : official journal of the Japan Pediatric Society.
[59] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[60] R. Holman,et al. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) , 1998, The Lancet.
[61] D. Goldstein,et al. What is hemoglobin A1c? An analysis of glycated hemoglobins by electrospray ionization mass spectrometry. , 1998, Clinical chemistry.
[62] P Wach,et al. Validation of Home Blood Glucose Meters With Respect to Clinical and Analytical Approaches , 1998, Diabetes Care.
[63] R. Holman,et al. UKPDS 28: A Randomized Trial of Efficacy of Early Addition of Metformin in Sulfonylurea-Treated Type 2 Diabetes , 1998, Diabetes Care.
[64] J. Rindone,et al. Effect of home blood glucose monitoring on the management of patients with non-insulin dependent diabetes mellitus in the primary care setting. , 1997, The American journal of managed care.
[65] F. Schellevis,et al. The Efficacy of Self-Monitoring of Blood Glucose in NIDDM subjects: A criteria-based literature review , 1997, Diabetes Care.
[66] J. Oki,et al. Frequency and Impact of SMBG on Glycemic Control in Patients With NIDDM in an Urban Teaching Hospital Clinic , 1997, The Diabetes educator.
[67] R. Hoffman,et al. Relationship between home glucose testing and hemoglobin Alc in type II diabetes patients. , 1997, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[68] Z. Trajanoski,et al. Accuracy of home blood glucose meters during hypoglycemia , 1996, Diabetes Care.
[69] M. Hanefeld,et al. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up , 1996, Diabetologia.
[70] V Marks,et al. Blood glucose: its measurement and clinical importance. , 1996, Clinica chimica acta; international journal of clinical chemistry.
[71] J. Colwell. Intensive Insulin Therapy in Type II Diabetes: Rationale and Collaborative Clinical Trial Results , 1996, Diabetes.
[72] L. Jaber,et al. Evaluation of a Pharmaceutical Care Model on Diabetes Management , 1996, The Annals of pharmacotherapy.
[73] Influence of Intensive Diabetes Treatment on Quality-of-Life Outcomes in the Diabetes Control and Complications Trial , 1996, Diabetes Care.
[74] H Lestradet,et al. [The discovery of insulin]. , 1996, Bulletin de l'Academie nationale de medecine.
[75] M. Morgan,et al. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. , 1995, The New England journal of medicine.
[76] Y. Yamasaki,et al. 1,5-Anhydro-D-glucitol Evaluates Daily Glycemic Excursions in Well-Controlled NIDDM , 1995, Diabetes Care.
[77] Charles M Peterson,et al. Tests of glycemia in diabetes. , 1995, Diabetes care.
[78] E. Araki,et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. , 1995, Diabetes research and clinical practice.
[79] W. Cefalu,et al. Glycohemoglobin measured by automated affinity HPLC correlates with both short-term and long-term antecedent glycemia. , 1994, Clinical chemistry.
[80] D. Rogers,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus , 1994 .
[81] D. Muchmore,et al. Self-monitoring of blood glucose in overweight type 2 diabetic patients , 1994, Acta Diabetologica.
[82] A. Prochazka,et al. Home blood glucose monitoring , 1993, Journal of General Internal Medicine.
[83] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[84] K. Shima,et al. The Response of GHb to Stepwise Plasma Glucose Change Over Time in Diabetic Patients , 1993, Diabetes Care.
[85] D. Nathan,et al. Implementation of capillary blood glucose monitoring in a teaching hospital and determination of program requirements to maintain quality testing. , 1992, The American journal of medicine.
[86] J. Yudkin,et al. Effect of Vitamin C on Glycosylation of Proteins , 1992, Diabetes.
[87] K. Wiener. The Effect of Haematocrit on Reagent Strip Tests for Glucose , 1991, Diabetic medicine : a journal of the British Diabetic Association.
[88] G V Gill,et al. Unexplained Deaths of Type 1 Diabetic Patients , 1991, Diabetic medicine : a journal of the British Diabetic Association.
[89] D. Giugliano,et al. Vitamin E Reduction of Protein Glycosylation in Diabetes: New Prospect for Prevention of Diabetic Complications? , 1991, Diabetes Care.
[90] G. Rutten,et al. Feasibility and effects of a diabetes type II protocol with blood glucose self-monitoring in general practice. , 1990, Family practice.
[91] M Hørder,et al. Effect of long-term monitoring of glycosylated hemoglobin levels in insulin-dependent diabetes mellitus. , 1990, The New England journal of medicine.
[92] E. DeLong,et al. Impact of Glucose Self-Monitoring on Non-lnsulin-Treated Patients With Type II Diabetes Mellitus: Randomized Controlled Trial Comparing Blood and Urine Testing , 1990, Diabetes Care.
[93] K. Mann,et al. Follow-up Intervention: Its Effect on Compliance Behavior to a Diabetes Regimen , 1990, The Diabetes educator.
[94] G. Slama,et al. Is glucose self-monitoring beneficial in non-insulin-treated diabetic patients? Results of a randomized comparative trial. , 1989, Diabete & metabolisme.
[95] T. Wysocki. Impact of blood glucose monitoring on diabetic control: Obstacles and interventions , 1989, Journal of Behavioral Medicine.
[96] L. Epstein,et al. Does self-monitoring of blood glucose levels improve dietary compliance for obese patients with type II diabetes? , 1986, The American journal of medicine.
[97] P. Zimmet,et al. Self‐monitoring of blood glucose levels in non‐insulin‐dependent diabetes mellitus , 1983, The Medical journal of Australia.
[98] D. Nathan,et al. Effect of aspirin on determinations of glycosylated hemoglobin. , 1983, Clinical chemistry.
[99] K. Alberti,et al. Safety of continuous subcutaneous insulin infusion: Metabolic deterioration and glycaemic autoregulation after deliberate cessation of infusion , 1982, Diabetologia.
[100] P. Sönksen,et al. HOME MONITORING OF BLOOD-GLUCOSE Method for Improving Diabetic Control , 1978, The Lancet.
[101] R. Tattersall,et al. SELF-MONITORING OF BLOOD-GLUCOSE Improvement of Diabetic Control , 1978, The Lancet.
[102] A. Cerami,et al. Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus. , 1976, The New England journal of medicine.
[103] P. Gallop,et al. The biosynthesis of human hemoglobin A1c. Slow glycosylation of hemoglobin in vivo. , 1976, The Journal of clinical investigation.
[104] O. Blumenfeld,et al. Studies of an unusual hemoglobin in patients with diabetes mellitus. , 1969, Biochemical and biophysical research communications.
[105] S. Genuth,et al. Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes: response to McCarter et al. , 2005, Diabetes care.
[106] Cas Weykamp,et al. IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. , 2004, Clinical chemistry.
[107] John M. Lachin,et al. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. , 2003, JAMA.
[108] Ilya Fine,et al. Glucose correlation with light scattering patterns--a novel method for non-invasive glucose measurements. , 2003, Diabetes technology & therapeutics.
[109] G J Kost,et al. Effects of drugs on glucose measurements with handheld glucose meters and a portable glucose analyzer. , 2000, American journal of clinical pathology.
[110] G M Steil,et al. Can interstitial glucose assessment replace blood glucose measurements? , 2000, Diabetes technology & therapeutics.
[111] W. Newman,et al. Impact of glucose self-monitoring on glycohemoglobin values in a veteran population. , 1990, Archives of internal medicine.